levodopa has been researched along with Neoplasms in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (25.00) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 5 (31.25) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Nishimori, I; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
Ashokan, A; Chandra Joshi, D; Jayakannan, M | 1 |
Ahmadieh-Yazdi, A; Beikzadeh, L; Fallah, P; Hashemi-Moghaddam, H; Madanchi, H; Mohammadzade, H | 1 |
Gao, X; Ning, Y | 1 |
Aharon-Peretz, J; Cohen, OS; Dagan, E; Djaldetti, R; Ephraty, L; Fixler Mehr, T; Friedman, E; Gershoni-Baruch, R; Hassin-Baer, S; Inzelberg, L; Inzelberg, R; Kaplan, N; Kozlova, E; Mory, A; Nitsan, Z; Schechtman, E; Schlesinger, I; Tunkel, O | 1 |
Jofre, IS; Lozano, RH | 1 |
Loria, DI; Rosso, S; Zanetti, R | 1 |
Ozawa, K | 1 |
Bolster, JM; Vaalburg, W; Van der Molen, HD; Van Dijk, T; Van Veen, W; Woldring, MG; Wynberg, H | 1 |
García-Foncillas, J; Roman, J; Salvador, J; Sierrasesúmaga, L; Villaizán, CJ | 1 |
Meco, G; Raschetti, R; Spila-Alegiani, S; Vanacore, N | 1 |
Bischoff, F; Bryson, G | 1 |
Klerman, GL; Krauthammer, C | 1 |
Kent, S | 1 |
4 review(s) available for levodopa and Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Cancer and Parkinson's disease: the odd couple.
Topics: Humans; Levodopa; Life Style; Melanoma; Neoplasms; Parkinson Disease; Smoking; Social Class | 2011 |
Parkinson's disease and cancer.
Topics: Antiparkinson Agents; Cohort Studies; Humans; Levodopa; Melanoma; Neoplasms; Parkinson Disease | 2007 |
[Gene therapy using AAV].
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Dependovirus; Fabry Disease; Genetic Therapy; Genetic Vectors; Hemophilia A; Humans; Levodopa; Neoplasms; Parkinson Disease | 2007 |
12 other study(ies) available for levodopa and Neoplasms
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines.
Topics: Amines; Amino Acids; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Conserved Sequence; Enzyme Activation; Humans; Isoenzymes; Kinetics; Molecular Sequence Data; Molecular Structure; Neoplasms; Sequence Alignment; Structure-Activity Relationship | 2008 |
l-Amino Acid Based Phenol- and Catechol-Functionalized Poly(ester-urethane)s for Aromatic π-Interaction Driven Drug Stabilization and Their Enzyme-Responsive Delivery in Cancer Cells.
Topics: Amino Acids; Antineoplastic Agents; Catechols; Doxorubicin; Drug Carriers; Esters; Levodopa; Neoplasms; Phenol; Phenols; Polymers; Urethane | 2022 |
Molecular imprinting of miR-559 on a peptide-immobilized poly L-DOPA/silica core-shell and in vitro investigating its effects on HER2-positive breast cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Levodopa; MicroRNAs; Molecular Imprinting; Neoplasms; Peptide Fragments; Receptor, ErbB-2; Silicon Dioxide | 2023 |
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.
Topics: Age of Onset; Aged; Antiparkinson Agents; Cross-Sectional Studies; Ethnicity; Female; Genetic Predisposition to Disease; Heterozygote; Humans; Jews; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Logistic Models; Male; Middle Aged; Mutation; Neoplasms; Parkinson Disease; Protein Serine-Threonine Kinases; Sex Factors; Survival Analysis | 2012 |
Novel use of L-dOPA in the treatment of anorexia and asthenia associated with cancer.
Topics: Anorexia; Asthenia; Dopamine Agents; Humans; Levodopa; Neoplasms; Palliative Care | 2002 |
Synthesis of no-carrier-added L- and D-[1-11C]-DOPA.
Topics: Brain; Dihydroxyphenylalanine; Humans; Isotope Labeling; Levodopa; Neoplasms; Radionuclide Imaging | 1983 |
Growth and growth hormone secretion in children with cancer treated with chemotherapy.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Height; Child; Child, Preschool; Clonidine; Dactinomycin; Dopamine Agents; Female; Follow-Up Studies; Growth; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Male; Neoplasms; Prospective Studies; Remission Induction; Retrospective Studies; Sex Factors; Time Factors | 1997 |
Mortality cancer risk in parkinsonian patients: a population-based study.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Neoplasms; Parkinson Disease; Poisson Distribution; Retrospective Studies; Rome; Selegiline | 1999 |
Short- and long-term effects of a massive dose of 6-OH-DA upon marsh mice.
Topics: Aggression; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Cannibalism; Female; Humans; Hydroxydopamines; Levodopa; Male; Maternal-Fetal Exchange; Mice; Neoplasms; Pregnancy; Time Factors | 1977 |
Secondary mania: manic syndromes associated with antecedent physical illness or drugs.
Topics: Adrenal Cortex Hormones; Adult; Bipolar Disorder; Bromides; Epilepsy, Temporal Lobe; Humans; Isoniazid; Levodopa; Middle Aged; Neoplasms; Neurocognitive Disorders; Postoperative Complications; Procarbazine; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotropic Drugs; Renal Dialysis | 1978 |
Continuous drug delivery methods reflect progress in therapy for chronic diseases.
Topics: Aged; Chronic Disease; Cytarabine; Dosage Forms; Drug Implants; Glaucoma; Humans; Injections, Intravenous; Leukemia; Levodopa; Neoplasms; Parkinson Disease; Pilocarpine; Research | 1977 |